ExchangeDEX+

Buy Crypto Markets Spot Futures500X Earn Events

PANews reported on December 23 that asset management company Amplify ETFs launched two new ETFs: Amplify Stablecoin Technology ETF (STBQ) and Amplify TokenizationPANews reported on December 23 that asset management company Amplify ETFs launched two new ETFs: Amplify Stablecoin Technology ETF (STBQ) and Amplify Tokenization

Amplify launches two new ETFs focusing on stablecoins and asset tokenization.

2025/12/23 21:40

PANews reported on December 23 that asset management company Amplify ETFs launched two new ETFs: Amplify Stablecoin Technology ETF (STBQ) and Amplify Tokenization Technology ETF (TKNQ), providing investors with investment opportunities in the stablecoin and asset tokenization sectors.

STBQ focuses on stablecoin technology, covering payment companies, crypto infrastructure providers, and stablecoin trading platforms. It tracks the MarketVector Stablecoin Technology Index and currently holds 24 assets, including spot crypto ETFs such as XRP, SOL, ETH, and LINK.

TKNQ focuses on asset tokenization technology, tracks the MarketVector Tokenization Technology Index, and holds 53 assets, covering both corporate and crypto assets that support the digitization of real-world assets.

Both ETFs have an expense ratio of 69 basis points and are now listed on the NYSE Arca exchange.

Market Opportunity

Index Cooperative Price(INDEX)

$0.4932

$0.4932$0.4932

+1.12%

USD

Index Cooperative (INDEX) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.